Could Insulin Resistance Be Driving Treatment-Resistant Depression? And How EXOMIND TMS Might Help
By Andrew J Hewitt, PMHNP-BC Abstract Treatment-resistant depression (TRD) remains a formidable clinical challenge. Emerging evidence suggests that metabolic dysregulation—particularly insulin resistance (IR)—may underlie or perpetuate depressive states unresponsive to standard therapies. This blog reviews recent evidence linking IR to antidepressant nonresponse, explores possible mechanistic pathways (neuroinflammation, blood–brain barrier dysfunction, neurotransmitter dysregulation), and describes how EXOMIND […]
Transcranial Magnetic Stimulation (TMS): A Promising Avenue for Traumatic Brain Injury (TBI) Recovery
Traumatic brain injury (TBI) can result in a constellation of debilitating symptoms, impacting cognitive, emotional, and physical functioning. Traditional treatment approaches often involve a combination of rehabilitation therapies and pharmacotherapy, but many individuals continue to experience persistent deficits. In recent years, transcranial magnetic stimulation (TMS) has emerged as a potential therapeutic intervention for TBI, offering […]